MDSpire - Takeaway
From the Journals

Early Results From a Trial of Active Surveillance for Low-Risk DCIS are ‘Reassuring,’ Say Researchers

“For women with low-risk DCIS, these interim results are reassuring. There is currently no indication that active surveillance leads to worse early outcomes compared with immediate surgery. It’s impor...

Share

  • 1

    LORD trial evaluates active surveillance vs immediate surgery for DCIS.

  • 2

    Presented at EBCC15 by Dr. Jelle Wesseling.

  • 3

    Involved 1,423 patients; monitored for two years.

  • 4

    6% of active surveillance patients developed invasive cancer.

  • 5

    9% in immediate surgery group developed invasive cancer.

  • 6

    Active surveillance does not mean withholding treatment.

  • 7

    Longer follow-up needed for conclusive results.

  • 8

    Study contributes to reducing overtreatment in breast cancer.

Original Source(s)

Early Results From a Trial of Active Surveillance for Low-Risk DCIS are ‘Reassuring,’ Say Researchers

  • by The ASCO Post Staff

  • April 1, 2026

Related Content

Could Mass Spec Overcome the CAR T Solid Tumor Barrier?

Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.

  • April 1, 2026

  • 8 min
From One Stem Cell to Millions of Cancer Killers

A three-step engineering strategy generates vast numbers of potent NK immune cells – potentially slashing the cost and scaling of cancer immunotherapy

  • April 1, 2026

  • 1 min
AI-Driven Multiagent System for Guiding First-Line Immunotherapy for NSCLC

An artificial intelligence (AI) multiagent system demonstrated correct and complete reasoning in determining the use of immunotherapy for patients with non–small cell lung cancer (NSCLC) in the first-...